Dr. Paul M. Bloomston
Claim this profileRegional Cancer Center-Lee Memorial Health System
Studies Cancer
Studies Non-Small Cell Lung Cancer
16 reported clinical trials
42 drugs studied
About Paul M. Bloomston
Education:
- Earned a Medical degree (MD) from an accredited medical school.
- Completed Residency in Radiation Oncology at the University of Florida College of Medicine – Jacksonville.
- Undertook a Fellowship in Stereotactic Radiosurgery and Brachytherapy at the University of Pittsburgh Medical Center.
Experience:
- Currently serves as a Radiation Oncologist at the Regional Cancer Center-Lee Memorial Health System.
- Specializes in stereotactic radiosurgery, brachytherapy, and general radiation oncology.
Area of expertise
1Cancer
Stage III
Stage IV
Stage I
2Non-Small Cell Lung Cancer
Stage II
Stage III
Stage I
Affiliated Hospitals
Clinical Trials Paul M. Bloomston is currently running
Genetic Testing
for Early-Stage Lung Cancer
This ALCHEMIST trial studies genetic testing in screening patients with stage IB-IIIA non-small cell lung cancer that has been or will be removed by surgery. Studying the genes in a patient's tumor cells may help doctors select the best treatment for patients that have certain genetic changes.
Recruiting0 awards N/A4 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
More about Paul M. Bloomston
Clinical Trial Related6 years of experience running clinical trials · Led 16 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Paul M. Bloomston has experience with
- Paclitaxel
- Irinotecan Hydrochloride
- Carboplatin
- Nivolumab
- Ipilimumab
- Gemcitabine Hydrochloride
Breakdown of trials Paul M. Bloomston has run
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Adenocarcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul M. Bloomston specialize in?
Paul M. Bloomston focuses on Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Cancer has involved Stage III patients, or patients who are Stage IV.
Is Paul M. Bloomston currently recruiting for clinical trials?
Yes, Paul M. Bloomston is currently recruiting for 9 clinical trials in Fort Myers Florida. If you're interested in participating, you should apply.
Are there any treatments that Paul M. Bloomston has studied deeply?
Yes, Paul M. Bloomston has studied treatments such as Paclitaxel, Irinotecan Hydrochloride, Carboplatin.
What is the best way to schedule an appointment with Paul M. Bloomston?
Apply for one of the trials that Paul M. Bloomston is conducting.
What is the office address of Paul M. Bloomston?
The office of Paul M. Bloomston is located at: Regional Cancer Center-Lee Memorial Health System, Fort Myers, Florida 33905 United States. This is the address for their practice at the Regional Cancer Center-Lee Memorial Health System.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.